2016 Q4 Form 10-K Financial Statement
#000114420417014986 Filed on March 16, 2017
Income Statement
Concept | 2016 Q4 | 2015 Q4 | 2015 Q3 |
---|---|---|---|
Revenue | $35.00K | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $1.200M | $1.120M | $790.0K |
YoY Change | 7.14% | 96.49% | -9.2% |
% of Gross Profit | |||
Research & Development | $2.090M | $1.140M | $1.010M |
YoY Change | 83.33% | -28.75% | 29.16% |
% of Gross Profit | |||
Depreciation & Amortization | $100.0K | $90.00K | $90.00K |
YoY Change | 11.11% | 12.5% | 0.0% |
% of Gross Profit | |||
Operating Expenses | $3.290M | $2.250M | $1.802M |
YoY Change | 46.22% | 3.69% | 9.28% |
Operating Profit | -$1.802M | ||
YoY Change | 144.17% | ||
Interest Expense | $970.0K | -$50.00K | $0.00 |
YoY Change | -2040.0% | -106.49% | |
% of Operating Profit | |||
Other Income/Expense, Net | -$50.00K | $0.00 | -$5.000K |
YoY Change | -100.0% | -100.34% | |
Pretax Income | -$2.330M | -$2.290M | -$1.810M |
YoY Change | 1.75% | 387.23% | -351.39% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$2.327M | -$2.294M | -$1.807M |
YoY Change | 1.44% | 384.99% | -352.37% |
Net Earnings / Revenue | -6648.57% | ||
Basic Earnings Per Share | -$0.11 | -$0.11 | -$0.09 |
Diluted Earnings Per Share | -$0.15 | -$0.11 | -$0.09 |
COMMON SHARES | |||
Basic Shares Outstanding | 21.20M shares | 20.06M shares | 20.06M shares |
Diluted Shares Outstanding | 20.06M shares |
Balance Sheet
Concept | 2016 Q4 | 2015 Q4 | 2015 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $14.00M | $7.900M | $9.700M |
YoY Change | 77.22% | -49.03% | 29.33% |
Cash & Equivalents | $14.01M | $7.857M | $9.690M |
Short-Term Investments | |||
Other Short-Term Assets | $200.0K | $200.0K | $300.0K |
YoY Change | 0.0% | 100.0% | 0.0% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $3.600M | $4.213M | $3.898M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $17.80M | $12.24M | $13.85M |
YoY Change | 45.38% | -37.48% | 16.39% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $800.0K | $1.043M | $1.059M |
YoY Change | -23.3% | -17.74% | -24.36% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $900.0K | $1.043M | $1.059M |
YoY Change | -13.71% | -17.74% | -18.54% |
TOTAL ASSETS | |||
Total Short-Term Assets | $17.80M | $12.24M | $13.85M |
Total Long-Term Assets | $900.0K | $1.043M | $1.059M |
Total Assets | $18.70M | $13.29M | $14.91M |
YoY Change | 40.74% | -36.28% | 12.95% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $3.000M | $4.158M | $4.038M |
YoY Change | -27.85% | -5.67% | -8.23% |
Accrued Expenses | $1.800M | $341.0K | $206.0K |
YoY Change | 427.86% | 34.25% | -58.8% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | ||
YoY Change | |||
Total Short-Term Liabilities | $4.857M | $4.853M | $4.594M |
YoY Change | 0.08% | -27.15% | -38.75% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $600.0K | $1.400M | $1.400M |
YoY Change | -57.14% | -75.0% | -6.67% |
Total Long-Term Liabilities | $0.00 | $1.400M | $1.400M |
YoY Change | -100.0% | -75.0% | -6.67% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.857M | $4.853M | $4.594M |
Total Long-Term Liabilities | $0.00 | $1.400M | $1.400M |
Total Liabilities | $5.476M | $6.297M | $5.992M |
YoY Change | -13.04% | -48.55% | -33.42% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$309.0M | -$314.1M | -$311.8M |
YoY Change | -1.63% | 3.72% | |
Common Stock | $297.9M | $297.8M | |
YoY Change | 0.01% | 2.98% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $13.19M | $6.990M | $8.917M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $18.67M | $13.29M | $14.91M |
YoY Change | 40.49% | -36.28% | 12.95% |
Cashflow Statement
Concept | 2016 Q4 | 2015 Q4 | 2015 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.327M | -$2.294M | -$1.807M |
YoY Change | 1.44% | 384.99% | -352.37% |
Depreciation, Depletion And Amortization | $100.0K | $90.00K | $90.00K |
YoY Change | 11.11% | 12.5% | 0.0% |
Cash From Operating Activities | -$2.410M | -$1.760M | -$1.760M |
YoY Change | 36.93% | 11.39% | 26.62% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$70.00K | -$70.00K | -$50.00K |
YoY Change | 0.0% | 400.0% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | -$70.00K | -$70.00K | -$50.00K |
YoY Change | 0.0% | 400.0% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 0.000 | 0.000 |
YoY Change | -100.0% | ||
NET CHANGE | |||
Cash From Operating Activities | -2.410M | -1.760M | -1.760M |
Cash From Investing Activities | -70.00K | -70.00K | -50.00K |
Cash From Financing Activities | 0.000 | 0.000 | 0.000 |
Net Change In Cash | -2.480M | -1.830M | -1.810M |
YoY Change | 35.52% | -122.82% | 29.29% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$2.410M | -$1.760M | -$1.760M |
Capital Expenditures | -$70.00K | -$70.00K | -$50.00K |
Free Cash Flow | -$2.340M | -$1.690M | -$1.710M |
YoY Change | 38.46% | 6.96% | 23.91% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2015Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
1444000 | USD |
CY2015Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-314099000 | USD |
CY2016Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
24300000 | USD |
CY2015Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
23261000 | USD |
CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
297855000 | USD |
CY2015Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
297828000 | USD |
CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11279000 | USD |
CY2015 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
4512000 | USD |
CY2015 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.56 | |
CY2015 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.56 | |
CY2015 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20053000 | shares |
CY2015 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
20053000 | shares |
CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4857000 | USD |
CY2016Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
619000 | USD |
CY2015Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4853000 | USD |
CY2016 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.25 | |
CY2016 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.20 | |
CY2016 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
20744000 | shares |
CY2016 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
21459000 | shares |
CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
5135000 | USD |
CY2016Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2015Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2016 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-825000 | USD |
CY2014 | us-gaap |
Licenses Revenue
LicensesRevenue
|
3646000 | USD |
CY2014 | us-gaap |
Revenues
Revenues
|
3646000 | USD |
CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
7121000 | USD |
CY2014 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1083000 | USD |
CY2014 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
17060000 | shares |
CY2016 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
37000 | USD |
CY2015 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
0 | USD |
CY2014 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
0 | USD |
CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3475000 | USD |
CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2403000 | USD |
CY2014 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
17057000 | shares |
CY2015Q4 | us-gaap |
Liabilities
Liabilities
|
6297000 | USD |
CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
18667000 | USD |
CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
13287000 | USD |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
13191000 | USD |
CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
6990000 | USD |
CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-308964000 | USD |
CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
5476000 | USD |
CY2016 | ttnp |
Incremental Common Shares Attributable To Assumed Exercise Of Warrants
IncrementalCommonSharesAttributableToAssumedExerciseOfWarrants
|
574000 | shares |
CY2016 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
5135000 | USD |
CY2015 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-11279000 | USD |
CY2014 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-3486000 | USD |
CY2014 | ttnp |
Incremental Common Shares Attributable To Assumed Exercise Of Warrants
IncrementalCommonSharesAttributableToAssumedExerciseOfWarrants
|
0 | shares |
CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1679000 | shares |
CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1286000 | shares |
CY2015 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1577000 | shares |
CY2015 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-8000 | USD |
CY2014 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-11000 | USD |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
5760000 | USD |
CY2014Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8611000 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
4747000 | USD |
CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
543000 | USD |
CY2015 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1026000 | USD |
CY2016 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1039000 | USD |
CY2015 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
|
14000 | USD |
CY2014 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
|
36000 | USD |
CY2015 | us-gaap |
Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
|
8646000 | USD |
CY2016 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
27000 | USD |
CY2016 | ttnp |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
0 | USD |
CY2016 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
377000 | USD |
CY2015 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
358000 | USD |
CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1039000 | USD |
CY2016 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-626000 | USD |
CY2016 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
63000 | USD |
CY2016 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | USD |
CY2015 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1671000 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
6293000 | USD |
CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-7466000 | USD |
CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
171000 | USD |
CY2015 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
133000 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-171000 | USD |
CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-133000 | USD |
CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
27000 | USD |
CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-14000 | USD |
CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
6149000 | USD |
CY2015 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-7613000 | USD |
CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
15470000 | USD |
CY2016 | ttnp |
Stock Issued From Vesting Of Restricted Stock
StockIssuedFromVestingOfRestrictedStock
|
0 | USD |
CY2015 | ttnp |
Stock Issued From Vesting Of Restricted Stock
StockIssuedFromVestingOfRestrictedStock
|
14000 | USD |
CY2014 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
353000 | USD |
CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
543000 | USD |
CY2014 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-850000 | USD |
CY2014 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-59000 | USD |
CY2014 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-3646000 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-5865000 | USD |
CY2014 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
18000 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-18000 | USD |
CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
9555000 | USD |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11798000 | USD |
CY2014 | ttnp |
Stock Issued From Vesting Of Restricted Stock
StockIssuedFromVestingOfRestrictedStock
|
36000 | USD |
CY2016 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
27000 | USD |
CY2015 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | USD |
CY2014 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | USD |
CY2016 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
0 | USD |
CY2015 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
0 | USD |
CY2014 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
9591000 | USD |
CY2016 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
1147000 | USD |
CY2015 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
112000 | USD |
CY2016 | ttnp |
Incremental Common Shares Attributable To Assumed Exercise Of Options
IncrementalCommonSharesAttributableToAssumedExerciseOfOptions
|
141000 | shares |
CY2015 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-11279000 | USD |
CY2014 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2403000 | USD |
CY2015 | ttnp |
Incremental Common Shares Attributable To Assumed Exercise Of Warrants
IncrementalCommonSharesAttributableToAssumedExerciseOfWarrants
|
0 | shares |
CY2014 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
172000 | USD |
CY2016 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1143000 | USD |
CY2015 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-250000 | USD |
CY2014 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-710000 | USD |
CY2016Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
14000000 | USD |
CY2016 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
4310000 | USD |
CY2015 | ttnp |
Incremental Common Shares Attributable To Assumed Exercise Of Options
IncrementalCommonSharesAttributableToAssumedExerciseOfOptions
|
0 | shares |
CY2014 | ttnp |
Incremental Common Shares Attributable To Assumed Exercise Of Options
IncrementalCommonSharesAttributableToAssumedExerciseOfOptions
|
3000 | shares |
CY2016 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
5100000 | USD |
CY2016Q4 | ttnp |
Class Of Warrants Fair Value Disclosure
ClassOfWarrantsFairValueDisclosure
|
619000 | USD |
CY2015Q4 | ttnp |
Class Of Warrants Fair Value Disclosure
ClassOfWarrantsFairValueDisclosure
|
1444000 | USD |
CY2014Q4 | ttnp |
Class Of Warrants Fair Value Disclosure
ClassOfWarrantsFairValueDisclosure
|
5578000 | USD |
CY2016 | ttnp |
Reclassification Of Underwriter Warrant
ReclassificationOfUnderwriterWarrant
|
0 | USD |
CY2015 | ttnp |
Reclassification Of Underwriter Warrant
ReclassificationOfUnderwriterWarrant
|
8646000 | USD |
CY2016 | ttnp |
Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
|
-825000 | USD |
CY2015 | ttnp |
Change In Fair Value Of Warrants
ChangeInFairValueOfWarrants
|
4512000 | USD |
CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3642000 | USD |
CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3265000 | USD |
CY2015 | ttnp |
Expense Incurred Under Research And License Agreements
ExpenseIncurredUnderResearchAndLicenseAgreements
|
3000 | USD |
CY2016 | ttnp |
Maximum Amount Eligible To Be Received On Achievement Of Sales Milestone
MaximumAmountEligibleToBeReceivedOnAchievementOfSalesMilestone
|
15000000 | USD |
CY2016 | ttnp |
Maximum Amount Eligible To Be Received On Achievement Of Regulatory Milestone
MaximumAmountEligibleToBeReceivedOnAchievementOfRegulatoryMilestone
|
15000000 | USD |
CY2016 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
257000 | USD |
CY2015 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
211000 | USD |
CY2014 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
209000 | USD |
CY2013Q1 | ttnp |
Gains Losses On Extinguishment Of Royalty Liability
GainsLossesOnExtinguishmentOfRoyaltyLiability
|
9000000 | USD |
CY2016 | ttnp |
Notional Liquidation Damages
NotionalLiquidationDamages
|
2500000 | USD |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2014Q4 | ttnp |
Underwritten Public Offering Proceeds From Units Issued
UnderwrittenPublicOfferingProceedsFromUnitsIssued
|
9600000 | USD |
CY2016 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1039000 | USD |
CY2015 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1026000 | USD |
CY2014 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
543000 | USD |
CY2016 | ttnp |
Share Based Compensation Expense Impact On Basic Earnings Per Share
ShareBasedCompensationExpenseImpactOnBasicEarningsPerShare
|
0.05 | |
CY2015 | ttnp |
Share Based Compensation Expense Impact On Basic Earnings Per Share
ShareBasedCompensationExpenseImpactOnBasicEarningsPerShare
|
0.05 | |
CY2014 | ttnp |
Share Based Compensation Expense Impact On Basic Earnings Per Share
ShareBasedCompensationExpenseImpactOnBasicEarningsPerShare
|
0.03 | |
CY2016 | ttnp |
Share Based Compensation Expense Impact On Diluted Earnings Per Share
ShareBasedCompensationExpenseImpactOnDilutedEarningsPerShare
|
0.05 | |
CY2015 | ttnp |
Share Based Compensation Expense Impact On Diluted Earnings Per Share
ShareBasedCompensationExpenseImpactOnDilutedEarningsPerShare
|
0.05 | |
CY2014 | ttnp |
Share Based Compensation Expense Impact On Diluted Earnings Per Share
ShareBasedCompensationExpenseImpactOnDilutedEarningsPerShare
|
0.03 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0153 | pure |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0188 | pure |
CY2016 | ttnp |
Estimated Forfeiture Rates For Options Granted To Management
EstimatedForfeitureRatesForOptionsGrantedToManagement
|
0.29 | pure |
CY2015 | ttnp |
Estimated Forfeiture Rates For Options Granted To Management
EstimatedForfeitureRatesForOptionsGrantedToManagement
|
0.3 | pure |
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y6M11D | |
CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y5M23D | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
|
0.0092 | pure |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
|
0.0116 | pure |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0204 | pure |
CY2014 | ttnp |
Estimated Forfeiture Rates For Options Granted To Management
EstimatedForfeitureRatesForOptionsGrantedToManagement
|
0.31 | pure |
CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y5M16D | |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
|
0.0165 | pure |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.10 | |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.67 | |
CY2016 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P10M17D | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
87267000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
91365000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
2637000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
3417000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
14322000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
13884000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
0 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
104226000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
|
0 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
1758000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-3840000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-268000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
108666000 | USD |
CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
104226000 | USD |
CY2015Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
108666000 | USD |
CY2015Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.11 | |
CY2014 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
592000 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-839000 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-187000 | USD |
CY2016 | ttnp |
Income Tax Reconciliation Book Gains Losses Not Currently Benefited
IncomeTaxReconciliationBookGainsLossesNotCurrentlyBenefited
|
-4439000 | USD |
CY2015 | ttnp |
Income Tax Reconciliation Book Gains Losses Not Currently Benefited
IncomeTaxReconciliationBookGainsLossesNotCurrentlyBenefited
|
2740000 | USD |
CY2014 | ttnp |
Income Tax Reconciliation Book Gains Losses Not Currently Benefited
IncomeTaxReconciliationBookGainsLossesNotCurrentlyBenefited
|
454000 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
659000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-20000 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
235000 | USD |
CY2016 | ttnp |
Income Tax Reconciliation Revaluation Of Warrant Liability
IncomeTaxReconciliationRevaluationOfWarrantLiability
|
-280000 | USD |
CY2015 | ttnp |
Income Tax Reconciliation Revaluation Of Warrant Liability
IncomeTaxReconciliationRevaluationOfWarrantLiability
|
1534000 | USD |
CY2014 | ttnp |
Income Tax Reconciliation Revaluation Of Warrant Liability
IncomeTaxReconciliationRevaluationOfWarrantLiability
|
-346000 | USD |
CY2016 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
252000 | USD |
CY2015 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
146000 | USD |
CY2014 | us-gaap |
Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
|
97000 | USD |
CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2015 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-1000 | USD |
CY2016 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
4400000 | USD |
CY2015 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
2700000 | USD |
CY2014 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
500000 | USD |
CY2015Q1 | us-gaap |
Revenues
Revenues
|
911000 | USD |
CY2015Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2294000 | USD |
CY2015Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.24 | |
CY2015Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.11 | |
CY2015Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2281000 | USD |
CY2015Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.09 | |
CY2015Q2 | us-gaap |
Revenues
Revenues
|
760000 | USD |
CY2015Q3 | us-gaap |
Revenues
Revenues
|
0 | USD |
CY2015Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.11 | |
CY2016Q2 | us-gaap |
Revenues
Revenues
|
15004000 | USD |
CY2016Q3 | us-gaap |
Revenues
Revenues
|
26000 | USD |
CY2016Q4 | us-gaap |
Revenues
Revenues
|
35000 | USD |
CY2016Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1846000 | USD |
CY2016Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
11928000 | USD |
CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2620000 | USD |
CY2016Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2327000 | USD |
CY2016Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.58 | |
CY2016Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.11 | |
CY2016Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.12 | |
CY2016 | dei |
Document Type
DocumentType
|
10-K | |
CY2016 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2016 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2016-12-31 | |
CY2016 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2016 | |
CY2016 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2016 | dei |
Entity Registrant Name
EntityRegistrantName
|
TITAN PHARMACEUTICALS INC | |
CY2016 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000910267 | |
CY2016 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2016 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2016 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2016 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2016 | dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | |
CY2016Q2 | dei |
Entity Public Float
EntityPublicFloat
|
113100000 | USD |
CY2016 | dei |
Trading Symbol
TradingSymbol
|
TTNP | |
CY2017Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
21198879 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2015Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2015Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2015Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2015Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2015Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
125000000 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
125000000 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
21198879 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
21198879 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
20059820 | shares |
CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
20059820 | shares |
CY2016Q2 | us-gaap |
Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
|
15000000 | USD |
CY2016 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1 for 5.5 reverse stock split effected in September 2015 | |
CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
4479000 | USD |
CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
4308000 | USD |
CY2014 | ttnp |
Expense Incurred Under Research And License Agreements
ExpenseIncurredUnderResearchAndLicenseAgreements
|
3000 | USD |
CY2015Q4 | us-gaap |
Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
|
0 | USD |
CY2016 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 12.2pt"> <strong><i>Use of Estimates</i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt 12.2pt"> <strong> </strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
277000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
287000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
299000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
308000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
155000 | USD |
CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1326000 | USD |
CY2016Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
1831000 | shares |
CY2016Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
3833000 | shares |
CY2015Q3 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
Board effected the Reverse Split of the outstanding shares of our common stock at a ratio of one (1) share for every five and one-half (5.5) shares outstanding, so that every five and one-half (5.5) outstanding shares of common stock before the Reverse Split represents one (1) share of common stock after the Reverse Split. | |
CY2016 | ttnp |
Effective Income Tax Rate Reconciliation Deduction Net Operating Loss Carryforward Expirations
EffectiveIncomeTaxRateReconciliationDeductionNetOperatingLossCarryforwardExpirations
|
-2741000 | USD |
CY2015 | ttnp |
Effective Income Tax Rate Reconciliation Deduction Net Operating Loss Carryforward Expirations
EffectiveIncomeTaxRateReconciliationDeductionNetOperatingLossCarryforwardExpirations
|
0 | USD |
CY2014 | ttnp |
Effective Income Tax Rate Reconciliation Deduction Net Operating Loss Carryforward Expirations
EffectiveIncomeTaxRateReconciliationDeductionNetOperatingLossCarryforwardExpirations
|
0 | USD |
CY2016 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.34 | pure |
CY2016Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
2002000 | shares |
CY2016 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P5Y8M5D | |
CY2016Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
5.67 | |
CY2016Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
1709000 | shares |
CY2016Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
|
5.77 | |
CY2016 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
|
2.47 | |
CY2016 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
|
17.21 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
|
0 | USD |
CY2015 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
|
0 | USD |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
|
0 | USD |
CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.52 | |
CY2015Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2016 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
825000 | USD |
CY2015 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-4512000 | USD |
CY2014 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
1083000 | USD |
CY2015 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-11300000 | USD |
CY2014 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2400000 | USD |
CY2012 | invest |
Investment Warrants Expiration Date
InvestmentWarrantsExpirationDate
|
2012-10-31 | |
CY2016Q4 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
13700000 | USD |
CY2015Q4 | us-gaap |
Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
|
7600000 | USD |
CY2014Q4 | ttnp |
Underwritten Public Offering Description Of Units Issued
UnderwrittenPublicOfferingDescriptionOfUnitsIssued
|
consisting of one share of common stock and 0.75 of a warrant (“Class A Warrant”) |